{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T01:28:49.855692+00:00","published_at":"2026-10-16T13:53:08.730534+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1c65n6heeoyw1","event_type":"CEO_CHANGED","effective_at":"2026-03-16","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:arun-swaminathan-ph-d","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:56d8b26f0386067ee3297aacf03a988efb45ae69b921d8f82022defe720f9d0e"],"summary":"Arun Swaminathan, Ph.D. executive of Coya Therapeutics, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j1m5891nachll","event_type":"CFO_CHANGED","effective_at":"2026-03-16","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:david-snyder-mba","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:48019c7688ed301590604d0ec65b25cbab831f4fd2c888ef922f396f9270c8c5"],"summary":"David Snyder, MBA executive of Coya Therapeutics, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:143r3xi1k9qaww","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-16","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:fred-grossman-do-fapa","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:d3682fffd0997c1b73c26ac742a75ea0e0b1f075ed5f4aa698eb13616d376ae7"],"summary":"Fred Grossman, DO, FAPA executive of Coya Therapeutics, Inc., effective 2026-03-16.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sns6b6mwm1uq","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:arun-swaminathan-ph-d","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Arun Swaminathan, Ph.D. seat on Coya Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fmnrbyfhhr4a","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:dieter-weinand","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Dieter Weinand seat on Coya Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zs5lz04w0ipi","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:wilbur-l-ross-jr","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Wilbur L. Ross, Jr. seat on Coya Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fj13481wnzhee","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:committee:coya-therapeutics-inc:audit-nominating-and-governance-chair","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Audit; Nominating and Governance · Chair committee of Coya Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17et682e5558e","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:dieter-weinand","alpha:committee:coya-therapeutics-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Dieter Weinand member of Audit; Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1scnxezq99nsp","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:anabella-villalobos-ph-d","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Anabella Villalobos, Ph.D. seat on Coya Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1jt2e9q1v369u6","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:ann-lee-ph-d-2","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Ann Lee, Ph.D. seat on Coya Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1injjlz1i52r39","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:dov-goldstein-m-d","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Dov Goldstein, M.D. seat on Coya Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1217sp01bpyc3k","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:howard-berman-ph-d","alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76"],"caused_claim_ids":["alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9"],"summary":"Howard Berman, Ph.D. seat on Coya Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:5","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anabella-villalobos-ph-d","object_label":"Anabella Villalobos, Ph.D.","object_source_name_forms":[],"value":"Anabella Villalobos, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anabella-villalobos-ph-d","name":"Anabella Villalobos, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:6","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ann-lee-ph-d-2","object_label":"Ann Lee, Ph.D.","object_source_name_forms":[],"value":"Ann Lee, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ann-lee-ph-d-2","name":"Ann Lee, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:7","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arun-swaminathan-ph-d","object_label":"Arun Swaminathan, Ph.D.","object_source_name_forms":[],"value":"Arun Swaminathan, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:arun-swaminathan-ph-d","name":"Arun Swaminathan, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:8","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dieter-weinand","object_label":"Dieter Weinand","object_source_name_forms":[],"value":"Dieter Weinand: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dieter-weinand","name":"Dieter Weinand"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:9","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dov-goldstein-m-d","object_label":"Dov Goldstein, M.D.","object_source_name_forms":[],"value":"Dov Goldstein, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dov-goldstein-m-d","name":"Dov Goldstein, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:10","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:howard-berman-ph-d","object_label":"Howard Berman, Ph.D.","object_source_name_forms":[],"value":"Howard Berman, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:howard-berman-ph-d","name":"Howard Berman, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:11","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:wilbur-l-ross-jr","object_label":"Wilbur L. Ross, Jr.","object_source_name_forms":[],"value":"Wilbur L. Ross, Jr.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:wilbur-l-ross-jr","name":"Wilbur L. Ross, Jr."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-05-16","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:12","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:arun-swaminathan-ph-d","object_label":"Arun Swaminathan, Ph.D.","object_source_name_forms":[],"value":"Arun Swaminathan, Ph.D.: Chief Executive Officer, Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:arun-swaminathan-ph-d","name":"Arun Swaminathan, Ph.D."},"title":"Chief Executive Officer, Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:56d8b26f0386067ee3297aacf03a988efb45ae69b921d8f82022defe720f9d0e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COYA 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T00:56:00.626282+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:13","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-snyder-mba","object_label":"David Snyder, MBA","object_source_name_forms":[],"value":"David Snyder, MBA: Chief Financial Officer, Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-snyder-mba","name":"David Snyder, MBA"},"title":"Chief Financial Officer, Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:48019c7688ed301590604d0ec65b25cbab831f4fd2c888ef922f396f9270c8c5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COYA 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T00:56:01.244221+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76:leadership_role:14","subject_id":"alpha:company:0b8e472c-af77-4dd4-ac6f-4adac7fa2d76","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:fred-grossman-do-fapa","object_label":"Fred Grossman, DO, FAPA","object_source_name_forms":[],"value":"Fred Grossman, DO, FAPA: President, Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:fred-grossman-do-fapa","name":"Fred Grossman, DO, FAPA"},"title":"President, Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-16","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-16","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:d3682fffd0997c1b73c26ac742a75ea0e0b1f075ed5f4aa698eb13616d376ae7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COYA 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T00:56:01.846358+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-16T00:00:00+00:00","effective_from":"2026-03-16","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:8dbca1af2b029dcf91fb8ee7cc99afb2fbd6fc7fbb4655d004e5d4de016aaac9","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Coya Therapeutics, Inc. DEF 14A 2025-05-16","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312525121779/d874040ddef14a.htm","source_date":"2025-05-16","retrieved_at":"2026-04-28T23:18:01.91+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:56d8b26f0386067ee3297aacf03a988efb45ae69b921d8f82022defe720f9d0e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COYA 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T00:56:00.626282+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:48019c7688ed301590604d0ec65b25cbab831f4fd2c888ef922f396f9270c8c5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COYA 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T00:56:01.244221+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d3682fffd0997c1b73c26ac742a75ea0e0b1f075ed5f4aa698eb13616d376ae7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"COYA 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm","source_date":"2026-03-16T00:00:00+00:00","retrieved_at":"2026-05-16T00:56:01.846358+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.845,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.856,"cross_source_agreement":0.75,"temporal_completeness":0.833},"diagnostics":{"published_claims":18,"factual_claims":18,"claims_with_linked_evidence":18,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:08.730534+00:00","observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":"2026-10-16T13:53:08.730534+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/coya-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/coya-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}